{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:11:22Z","timestamp":1785528682317,"version":"3.56.0"},"reference-count":37,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.2967\/jnumed.123.266158","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T17:45:24Z","timestamp":1701366324000},"page":"63-70","source":"Crossref","is-referenced-by-count":13,"title":["Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective\u2013Prospective [<sup>68<\/sup>Ga]Ga-PSMA-11 PET\/CT Study"],"prefix":"10.2967","volume":"65","author":[{"given":"Kilian","family":"Kluge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Einspieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Spielvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stoiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysoula","family":"Vraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Wunsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gero","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Grubm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"2024011701100702000_65.1.63.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2024011701100702000_65.1.63.2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00858"},{"key":"2024011701100702000_65.1.63.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4016"},{"key":"2024011701100702000_65.1.63.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.011"},{"key":"2024011701100702000_65.1.63.5","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10661"},{"key":"2024011701100702000_65.1.63.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.126094"},{"key":"2024011701100702000_65.1.63.7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol."},{"key":"2024011701100702000_65.1.63.8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.23736\/S0393-2249.18.03081-3","article-title":"The role of 68Ga-PSMA PET\/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature","volume":"70","author":"Eissa","year":"2018","journal-title":"Minerva Urol Nefrol."},{"key":"2024011701100702000_65.1.63.9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41391-022-00544-3","article-title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Pozdnyakov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2024011701100702000_65.1.63.10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.eururo.2020.12.037","article-title":"Quantitative and qualitative analysis of blood-based liquid biopsies to inform clinical decision-making in prostate cancer","volume":"79","author":"Casanova-Salas","year":"2021","journal-title":"Eur Urol."},{"key":"2024011701100702000_65.1.63.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00665-9"},{"key":"2024011701100702000_65.1.63.12","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/48.3.421"},{"key":"2024011701100702000_65.1.63.13","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.688023"},{"key":"2024011701100702000_65.1.63.14","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9629-x"},{"key":"2024011701100702000_65.1.63.15","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res."},{"key":"2024011701100702000_65.1.63.16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3066"},{"key":"2024011701100702000_65.1.63.17","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1038\/s41598-021-84507-z","article-title":"Cell-free DNA concentration and fragment size as a biomarker for prostate cancer","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep."},{"key":"2024011701100702000_65.1.63.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2003.11.023"},{"key":"2024011701100702000_65.1.63.19","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.2147\/OTT.S100901","article-title":"Cell-free DNA as a diagnostic marker for cancer: current insights","volume":"9","author":"Salvi","year":"2016","journal-title":"Onco Targets Ther."},{"key":"2024011701100702000_65.1.63.20","doi-asserted-by":"crossref","unstructured":"Ulz P Belic J Graf R . Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer. Nat Commun. 2016;7:12008.","DOI":"10.1038\/ncomms12008"},{"key":"2024011701100702000_65.1.63.21","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ijc.31397","article-title":"Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide","volume":"143","author":"Belic","year":"2018","journal-title":"Int J Cancer."},{"key":"2024011701100702000_65.1.63.22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-021-01445-0","article-title":"Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies","volume":"21","author":"Dillinger","year":"2022","journal-title":"Mol Cancer."},{"key":"2024011701100702000_65.1.63.23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1538-7445.AM2022-532","article-title":"Circulating tumor DNA and outcomes with lutetium-PSMA in advanced prostate cancer: preliminary results from an Australian study [abstract]","volume":"82(suppl)","author":"Fettke","year":"2022","journal-title":"Cancer Res."},{"key":"2024011701100702000_65.1.63.24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2018.02.013","article-title":"Plasma cell-free DNA concentration and outcomes from taxane therapy in metastatic castration-resistant prostate cancer from two phase III trials (FIRSTANA and PROSELICA)","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol."},{"key":"2024011701100702000_65.1.63.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.04.055"},{"key":"2024011701100702000_65.1.63.26","doi-asserted-by":"crossref","unstructured":"Alongi P Laudicella R Lanzafame H . PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature. Cancers (Basel). 2022;14:1770.","DOI":"10.3390\/cancers14071770"},{"key":"2024011701100702000_65.1.63.27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1752-8062.2011.00375.x","article-title":"Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET\/CT imaging in chemotherapy-treated advanced prostate cancer","volume":"5","author":"Kwee","year":"2012","journal-title":"Clin Transl Sci."},{"key":"2024011701100702000_65.1.63.28","doi-asserted-by":"crossref","unstructured":"Combes AD Palma CA Calopedos R . PSMA PET-CT in the diagnosis and staging of prostate cancer. Diagnostics (Basel). 2022;12:2594.","DOI":"10.3390\/diagnostics12112594"},{"key":"2024011701100702000_65.1.63.29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41391-022-00544-3","article-title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Pozdnyakov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2024011701100702000_65.1.63.30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/pros.23778","article-title":"Clinical determinants for successful circulating tumor DNA analysis in prostate cancer","volume":"79","author":"Schweizer","year":"2019","journal-title":"Prostate."},{"key":"2024011701100702000_65.1.63.31","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/brv.12413","article-title":"The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature","volume":"93","author":"Aucamp","year":"2018","journal-title":"Biol Rev Camb Philos Soc."},{"key":"2024011701100702000_65.1.63.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2010.11.001"},{"key":"2024011701100702000_65.1.63.33","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12058"},{"key":"2024011701100702000_65.1.63.34","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-013-0491-2"},{"key":"2024011701100702000_65.1.63.35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bju.13586","article-title":"Liquid biopsy: ready to guide therapy in advanced prostate cancer?","volume":"118","author":"Hegemann","year":"2016","journal-title":"BJU Int."},{"key":"2024011701100702000_65.1.63.36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.100"},{"key":"2024011701100702000_65.1.63.37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12149-021-01610-x","article-title":"Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?","volume":"35","author":"Has Simsek","year":"2021","journal-title":"Ann Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.266158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T09:10:45Z","timestamp":1705482645000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.266158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,2]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.2967\/jnumed.123.266158"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.266158","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}